SARS-CoV-2 mRNA Vaccine ARCT-021
RG1125827
Phase 2 mab active
Quick answer
SARS-CoV-2 mRNA Vaccine ARCT-021 for Hematopoietic and Lymphatic System Neoplasm is a Phase 2 program (mab) at Arcturus Therapeutics Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcturus Therapeutics Holdings
- Indication
- Hematopoietic and Lymphatic System Neoplasm
- Phase
- Phase 2
- Modality
- mab
- Status
- active